Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03617666
Title Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study (AVENuE)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications

Hodgkin's lymphoma

Therapies

Avelumab

Age Groups: adult | child
Covered Countries


No variant requirements are available.